Healthcare

26 Dec 2017  |  Latin America  |  Market Research

PACS and Integrated PACS Market Assessment in Brazil, Forecast to 2021

SaaS Models, Integrated Analytics Tools on the Rise, Further Advancing Market Maturity

Infographics

×

Key Issues Addressed

Brazil currently spends over $80 million on PACS and integrated PACS systems, considering only the software involved. The overall penetration is increasing, although adoption varies significantly among geographical regions and by the size of institutions. While large-size hospitals and diagnostic centers are almost fully penetrated and are almost e...

Brazil’s telemedicine market is likely to increase from $495.3 million in 2015 to $743.8 million in 2017 whereas the mHealth market revenue will grow from $446.8 million to $1.43 billion over the same period. Telemedicine is strongly focused on teleradiology in Brazil, which represents over 98% of the market segment revenue. Other telemedicine ap...

Healthcare interoperability is a global challenge for industry stakeholders. While a number of organizations are working towards developing and implementing industry standards, challenges emerge every day as technologies and their uses evolve. Advances in Big Data, genomics, and pharmacy information technology (IT) are helping to identify new appli...

This research service analyzes the Argentinean, Brazilian, and Mexican picture archiving communication system (PACS) market regarding its revenue, installed base, market share, and competitive scenario. Although the region is still far behind North America and Europe in terms of penetration of the solutionswhere the installed base reaches more tha...

This research service analyzes the Brazilian healthcare system through the revenue of pharmaceutical and biotechnology drugs, medical devices, medical equipment, clinical diagnostics, and administrative clinical healthcare IT systems. It also delivers an overview of the Brazilian Unified Health System (the SUS) as well as an overview of Brazils ...

This research service considers the biologics market in Brazil. It covers the markets move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key marke...

This research study covers the Brazilian patient monitoring market, focusing on three specific segments: critical care, acute care and vital signs.

This study provides a comprehensive overview of the Latin American rheumatoid arthritis Drugs Market. Researched countries encompass Brazil and the Southern Cone (Chile and Argentina). Included are competitive profiles, distribution network discussions, pricing analysis, drug pipelines, regulatory issues, major market drivers and restraints, market...

This research service covers the Latin America Cardiovascular drugs market from 2004 to 2011, with 2006 as the base year. Major markets were studied: Brazil and the Andean Region (which includes Colombia and Venezuela, countries that are estimated to achieve double digit growth rates in the forecast period).